Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE3.8600
- TODAY'S CHANGE (%)0.3100 (8.7324%)
- Bid / Lots3.6500/ 5
- Ask / Lots3.9300/ 1
- Open / Previous Close3.6300 / 3.5500
- Day Range
- 52 Week Range
- Volume1,389,104
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 37782 | 3.67 |
| 09:34 ET | 710 | 3.66 |
| 09:36 ET | 3400 | 3.645 |
| 09:38 ET | 2736 | 3.59 |
| 09:39 ET | 2005 | 3.6 |
| 09:41 ET | 9583 | 3.66 |
| 09:43 ET | 4458 | 3.68 |
| 09:45 ET | 600 | 3.66 |
| 09:50 ET | 1100 | 3.645 |
| 09:52 ET | 2919 | 3.69 |
| 09:54 ET | 1400 | 3.695 |
| 09:56 ET | 1291 | 3.725 |
| 09:57 ET | 829 | 3.725 |
| 09:59 ET | 1002 | 3.74 |
| 10:01 ET | 6593 | 3.69 |
| 10:03 ET | 4683 | 3.6915 |
| 10:06 ET | 400 | 3.705 |
| 10:08 ET | 3921 | 3.705 |
| 10:10 ET | 1200 | 3.745 |
| 10:12 ET | 1733 | 3.745 |
| 10:15 ET | 9300 | 3.75 |
| 10:17 ET | 300 | 3.75 |
| 10:21 ET | 15905 | 3.7102 |
| 10:24 ET | 330 | 3.71 |
| 10:26 ET | 3400 | 3.72 |
| 10:28 ET | 5306 | 3.73 |
| 10:30 ET | 1500 | 3.74 |
| 10:32 ET | 5919 | 3.735 |
| 10:33 ET | 3700 | 3.71 |
| 10:35 ET | 2584 | 3.72 |
| 10:37 ET | 1900 | 3.735 |
| 10:39 ET | 500 | 3.7305 |
| 10:42 ET | 7642 | 3.745 |
| 10:44 ET | 2372 | 3.725 |
| 10:46 ET | 420 | 3.7118 |
| 10:48 ET | 1440 | 3.725 |
| 10:50 ET | 100 | 3.725 |
| 10:51 ET | 800 | 3.725 |
| 10:53 ET | 587 | 3.7296 |
| 10:55 ET | 1171 | 3.75 |
| 10:57 ET | 1603 | 3.74 |
| 11:00 ET | 100 | 3.73 |
| 11:02 ET | 930 | 3.745 |
| 11:04 ET | 300 | 3.75 |
| 11:06 ET | 800 | 3.745 |
| 11:08 ET | 200 | 3.745 |
| 11:09 ET | 2479 | 3.745 |
| 11:11 ET | 8929 | 3.72 |
| 11:13 ET | 6483 | 3.74 |
| 11:15 ET | 300 | 3.735 |
| 11:18 ET | 1175 | 3.725 |
| 11:20 ET | 400 | 3.725 |
| 11:22 ET | 200 | 3.725 |
| 11:24 ET | 300 | 3.7201 |
| 11:26 ET | 722 | 3.725 |
| 11:27 ET | 2384 | 3.74 |
| 11:29 ET | 488 | 3.735 |
| 11:31 ET | 10896 | 3.7382 |
| 11:33 ET | 1800 | 3.745 |
| 11:36 ET | 100 | 3.745 |
| 11:38 ET | 6082 | 3.745 |
| 11:40 ET | 300 | 3.735 |
| 11:42 ET | 100 | 3.735 |
| 11:44 ET | 142 | 3.735 |
| 11:45 ET | 3701 | 3.75 |
| 11:47 ET | 558 | 3.755 |
| 11:49 ET | 500 | 3.7501 |
| 11:51 ET | 4032 | 3.745 |
| 11:54 ET | 1910 | 3.75 |
| 11:56 ET | 210 | 3.75 |
| 11:58 ET | 4362 | 3.755 |
| 12:00 ET | 1793 | 3.755 |
| 12:02 ET | 400 | 3.75 |
| 12:03 ET | 800 | 3.7511 |
| 12:05 ET | 500 | 3.755 |
| 12:07 ET | 7790 | 3.7601 |
| 12:09 ET | 100 | 3.7601 |
| 12:12 ET | 1600 | 3.78 |
| 12:14 ET | 2400 | 3.79 |
| 12:16 ET | 1981 | 3.785 |
| 12:18 ET | 600 | 3.785 |
| 12:20 ET | 647 | 3.785 |
| 12:21 ET | 5126 | 3.775 |
| 12:23 ET | 626 | 3.775 |
| 12:25 ET | 3900 | 3.77 |
| 12:27 ET | 100 | 3.77 |
| 12:30 ET | 41941 | 3.755 |
| 12:34 ET | 100 | 3.75 |
| 12:36 ET | 3632 | 3.77 |
| 12:38 ET | 1500 | 3.78 |
| 12:39 ET | 680 | 3.775 |
| 12:41 ET | 1554 | 3.79 |
| 12:43 ET | 300 | 3.785 |
| 12:45 ET | 1684 | 3.78 |
| 12:48 ET | 500 | 3.77 |
| 12:50 ET | 327 | 3.775 |
| 12:52 ET | 2200 | 3.77 |
| 12:54 ET | 2614 | 3.78 |
| 12:56 ET | 478 | 3.78 |
| 12:57 ET | 10151 | 3.805 |
| 12:59 ET | 711 | 3.805 |
| 01:01 ET | 8430 | 3.815 |
| 01:03 ET | 375 | 3.815 |
| 01:06 ET | 7477 | 3.83 |
| 01:08 ET | 1000 | 3.83 |
| 01:10 ET | 800 | 3.84 |
| 01:12 ET | 2200 | 3.8401 |
| 01:14 ET | 8910 | 3.85 |
| 01:15 ET | 7379 | 3.865 |
| 01:17 ET | 8960 | 3.855 |
| 01:19 ET | 558 | 3.855 |
| 01:24 ET | 1600 | 3.86 |
| 01:26 ET | 8359 | 3.845 |
| 01:28 ET | 527 | 3.85 |
| 01:30 ET | 66590 | 3.825 |
| 01:32 ET | 975 | 3.82 |
| 01:33 ET | 200 | 3.825 |
| 01:35 ET | 2530 | 3.825 |
| 01:37 ET | 6676 | 3.8419 |
| 01:39 ET | 3922 | 3.86 |
| 01:42 ET | 981 | 3.86 |
| 01:44 ET | 5091 | 3.865 |
| 01:46 ET | 1300 | 3.8517 |
| 01:48 ET | 100 | 3.855 |
| 01:50 ET | 424 | 3.855 |
| 01:51 ET | 100 | 3.86 |
| 01:53 ET | 1282 | 3.86 |
| 01:55 ET | 250 | 3.8591 |
| 01:57 ET | 1000 | 3.86 |
| 02:02 ET | 4792 | 3.845 |
| 02:04 ET | 10388 | 3.83 |
| 02:06 ET | 10043 | 3.84 |
| 02:08 ET | 525 | 3.84 |
| 02:09 ET | 100 | 3.84 |
| 02:13 ET | 300 | 3.85 |
| 02:15 ET | 1018 | 3.85 |
| 02:18 ET | 728 | 3.845 |
| 02:20 ET | 6679 | 3.82 |
| 02:22 ET | 9028 | 3.845 |
| 02:24 ET | 1100 | 3.85 |
| 02:26 ET | 175 | 3.855 |
| 02:27 ET | 100 | 3.86 |
| 02:29 ET | 5673 | 3.84 |
| 02:31 ET | 100 | 3.845 |
| 02:33 ET | 399 | 3.8414 |
| 02:36 ET | 5718 | 3.845 |
| 02:38 ET | 975 | 3.845 |
| 02:40 ET | 5423 | 3.86 |
| 02:42 ET | 1045 | 3.855 |
| 02:44 ET | 24882 | 3.855 |
| 02:45 ET | 1046 | 3.8501 |
| 02:47 ET | 600 | 3.85 |
| 02:49 ET | 100 | 3.855 |
| 02:51 ET | 100 | 3.855 |
| 02:54 ET | 100 | 3.855 |
| 02:56 ET | 5204 | 3.845 |
| 02:58 ET | 884 | 3.85 |
| 03:00 ET | 43561 | 3.8401 |
| 03:02 ET | 490 | 3.845 |
| 03:03 ET | 300 | 3.845 |
| 03:05 ET | 7223 | 3.825 |
| 03:07 ET | 1048 | 3.825 |
| 03:09 ET | 2343 | 3.835 |
| 03:14 ET | 11575 | 3.86 |
| 03:16 ET | 1754 | 3.87 |
| 03:18 ET | 2277 | 3.88 |
| 03:20 ET | 3900 | 3.89 |
| 03:21 ET | 4569 | 3.89 |
| 03:23 ET | 5046 | 3.895 |
| 03:25 ET | 2216 | 3.895 |
| 03:27 ET | 10280 | 3.885 |
| 03:30 ET | 745 | 3.885 |
| 03:32 ET | 2357 | 3.885 |
| 03:34 ET | 3680 | 3.885 |
| 03:36 ET | 2886 | 3.885 |
| 03:38 ET | 3023 | 3.89 |
| 03:39 ET | 18345 | 3.855 |
| 03:41 ET | 9249 | 3.84 |
| 03:43 ET | 5352 | 3.855 |
| 03:45 ET | 3959 | 3.865 |
| 03:48 ET | 5447 | 3.875 |
| 03:50 ET | 23865 | 3.85 |
| 03:52 ET | 2219 | 3.845 |
| 03:54 ET | 15535 | 3.855 |
| 03:56 ET | 40855 | 3.875 |
| 03:57 ET | 56311 | 3.88 |
| 03:59 ET | 391217 | 3.86 |
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 11, 2024
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors, from 4:30PM ET on Thursday Apr 11, 2024 by Dow Jones
4:30PM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 10, 2024
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum, from 7:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
7:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 2.7B | -2.5x | --- |
MoonLake Immunotherapeutics | 2.7B | -55.7x | --- |
CG Oncology Inc | 2.7B | -38.4x | --- |
Apogee Therapeutics Inc | 2.7B | -27.1x | --- |
Janux Therapeutics Inc | 2.4B | -35.3x | --- |
Merus NV | 2.6B | -15.1x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Chief Operating Officer, Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 701.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.15 |
EPS | $-1.54 |
Book Value | $0.11 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
